TMVD Drug Raw Materials Production-Distribution
The stored series is adjusted. Raw is the price the exchange quoted that day.
- High
- 61,590
- Low
- 10,342
- Period change
- up368.39%
Board events
- Sell queue: 616,995 shares offered at 52,790 Rial.
- 3 consecutive lower closes.
Trading board
- Last trade
52,790Rial
- down3.00%
- Ask queue
- Closing price
53,030Rial
- down2.55%
- Yesterday's close
54,420Rial
- Daily price band
- 52,790–56,050
- Market cap
148trillion Rial
- Earnings per share (EPS)
- 5,718
- Price/earnings (P/E)
- 9.30
- Shares outstanding
2.8billion
- Trades
- 954
- Volume
4.3million
- Turnover
226billion Rial
- Retail · Buy
2.9million
- Retail · Sell
3.5million
- Institutional · Buy
1.4million
- Institutional · Sell
756,342
- Net retail
- 630,472
- Buyer-to-seller strength
- 0.41
Fundamentals
- EPS (trailing twelve months)
5,718Rial
- Price to earnings (P/E)
- 9.27
- Sector P/E
- 12.94
- Price to sales (P/S)
- 2.95
- Sales per share
17,955Rial
- Free float
- 23.00%
- Average monthly volume
6.3million
- Sector
- مواد و محصولات دارویی
- Market
- بازار بورس
- Board
- بازار اول (تابلوی فرعی) بورس
- Updated
- Sep 16, 2026
Major shareholders
Holdings as counted for the assembly of Jul 7, 2026. The named holders together held 77.82% of the shares.
Shareholder register
The Tehran exchange register, as of Sep 14, 2026. The named holders together hold 82.24% of the shares.
Source: the Tehran exchange's daily shareholder register. The exchange names only holders at roughly one percent and above, so this is a floor on known ownership: the rest is spread across smaller holders it does not name.
Board of directors
Source: the codal filing that announced each election; every name links to its own letter.
Retail flow history
| Date | Net retail |
|---|---|
| Aug 18, 2026 | 313,000 |
| Aug 19, 2026 | 253,000 |
| Aug 22, 2026 | 315,099 |
| Aug 24, 2026 | 2,910,575 |
| Aug 25, 2026 | -2,195,189 |
| Aug 29, 2026 | 1,783,941 |
| Aug 31, 2026 | 1,409,189 |
| Sep 1, 2026 | -4,857,324 |
| Sep 2, 2026 | 395,368 |
| Sep 5, 2026 | 2,780,454 |
| Sep 8, 2026 | -3,492,364 |
| Sep 9, 2026 | -61,027 |
| Sep 12, 2026 | -2,978,692 |
| Sep 14, 2026 | -2,821,386 |
| Sep 15, 2026 | -833,230 |
- Retail buy per capita
583,842,213Rial
- Retail sell per capita
1,657,019,799Rial
Values in this window are estimated: volume times the same day closing price.
Price statistics
52-week range
- Today's rank in its market
- 718 of 736
- From 52-week high
- down11.94%
- 20-day volatility
- 2.47%
- 20-day average
55,548Rial
- 50-day average
47,290Rial
- 30-day average volume
- 6.4million
- Correlation with the dollar (30d)
- 0.10
- Correlation with the dollar (90d)
- -0.11
As of Sep 16, 2026
All-time high and low
- All-time high
59,950Rial
Sep 5, 2026- All-time low
6.01Rial
Mar 3, 2009- From the all-time high
- down11.94%
- Deepest fall (5 years)
- down41.84%Jan 15, 2025 to Sep 24, 2025
Returns
Same group
Recent records
Symbol timeline
Daroupakhsh Raw Materials Loses Preferential Currency for Its Pharmaceutical Inputs
Daroupakhsh Pharmaceutical Raw Materials Manufacturing Company, traded under the symbol Detmad (TMVD) on the Tehran Stock Exchange, said in a disclosure on the Codal system on Wednesday, August 19, 2026 (28 Mordad 1405), according to Ecoiran citing Hamshahri, that under a letter from Iran's Food and Drug Administration reclassifying products made by pharmaceutical raw material manufacturers, the company was removed from eligibility for preferential currency as of August 16, 2026 (25 Mordad 1405). As a result, the company will now purchase intermediate materials using the negotiated market exchange rate. The company said in its disclosure that pricing for all of its products will no longer be subject to Food and Drug Administration price controls, and will instead be set based on updated production costs and competitive market conditions. The change is part of a broader policy of gradually phasing out preferential currency for imported pharmaceutical inputs, which could affect the cost structure of raw material producers and the final price of some medicines.
Supervisor messageReopening of trading symbols (SAMA), (PRDZ), (TMLT), (TMVD)
It is hereby announced that the trading symbols of Ama Industrial Company (SAMA), Pardis Petrochemical (PRDZ), Bank Mellat Investment (TMLT), and Daroupakhsh Raw Materials Production (TMVD), following the disclosure of Group B material information, are ready for trading with price fluctuation limits. Tehran Stock Exchange Market Operations Management
Supervisor messageHalt of the symbol (TMVD1) due to disclosure of material information Group B
It is hereby announced that the trading symbol of Todaroo Movad Avalie Dahroopakhsh Company (TMVD1) has been halted due to the disclosure of material information Group B. The said symbol will reopen no later than 10:15 on the next trading day with price fluctuation range restrictions. Stock Market Operations Management, Tehran Stock Exchange (TSE)
Respectfully, in view of letter No. 28770/665 dated 1405/05/25 from the Food and Drug Administration regarding changes to the commodity group of all products of raw pharmaceutical material producing companies, please be informed that as of the date of the said letter, the company has been excluded from receiving preferential currency, and the purchase of intermediate materials will be carried out using negotiated currency. Therefore, the pricing of all products of this company will no longer be subject to the pricing of the Food and Drug Administration, and pricing will be carried out taking into account the new cost of goods and the competitive conditions of the market. However, the pricing of orders that have been allocated preferential currency is subject to the commodity group's policy-making at the time of customs clearance of the goods. It should be noted that the profit and loss effects of this event are not yet determined and will be announced subsequently.
- Elimination of preferential exchange rate
- Event date
- 1405/05/26
- Event description
- Respectfully, in view of letter No. 28770/665 dated 1405/05/25 from the Food and Drug Administration regarding changes to the commodity group of all products of raw pharmaceutical material producing companies, please be informed that as of the date of the said letter, the company has been excluded from receiving preferential currency, and the purchase of intermediate materials will be carried out using negotiated currency. Therefore, the pricing of all products of this company will no longer be subject to the pricing of the Food and Drug Administration, and pricing will be carried out taking into account the new cost of goods and the competitive conditions of the market. However, the pricing of orders that have been allocated preferential currency is subject to the commodity group's policy-making at the time of customs clearance of the goods. It should be noted that the profit and loss effects of this event are not yet determined and will be announced subsequently.
Supervisor messageReopening of trading symbols (OFOG), (TRIR), (TMVD), (DDPK)
It is hereby announced that the trading symbols of the companies Okhoravan Chain Stores (OFOG), Iran Tractor Manufacturing (TRIR), Daroupakhsh Raw Material Production (TMVD), and Daroupakhsh Pharmaceutical Chemistry (DDPK), following the holding of the annual general meeting regarding the distribution of cash dividends, are ready for trading without price fluctuation limits using the auction mechanism. Tehran Stock Exchange Market Operations Management